Related Experiment Videos

Congenital hypothyroidism clinical aspects and late consequences

Atilla Büyükgebiz1

  • 1Dokuz Eylül Faculty of Medicine, Department of Pediatric Endocrinology and Adolescence Inciralti, Izmir, Türkiye. atilla.buyukgebiz@deu.edu.tr

Insights

Early diagnosis and treatment of congenital hypothyroidism (CH) are crucial to prevent mental retardation and neurological deficits. Prompt intervention with L-thyroxine improves long-term outcomes for affected infants.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Congenital hypothyroidism (CH) is a leading preventable cause of intellectual disability.
  • Delayed diagnosis increases the risk of severe neurological sequelae.
  • Thyroid dysgenesis accounts for 85-90% of permanent CH cases, with candidate genes including TTF1, TTF2, and PAX8.

Purpose of the Study:

  • To summarize the importance of timely diagnosis and treatment of congenital hypothyroidism.
  • To highlight the causes, diagnostic methods, and management strategies for CH.
  • To emphasize the impact of early intervention on neurodevelopmental outcomes.

Main Methods:

  • Review of prevalence, causes, and clinical manifestations of CH.
  • Description of diagnostic criteria including elevated TSH and decreased T4 levels.
  • Outline of imaging and biochemical tests for thyroid assessment.
  • Discussion of treatment protocols and follow-up strategies.

Main Results:

  • Early treatment (before 2 weeks) with appropriate L-thyroxine doses (10-15 µg/kg/day) leads to better long-term outcomes.
  • Noncompliance with treatment is a significant challenge in patient follow-up.
  • Despite treatment, severe in utero hypothyroidism can still result in intellectual deficits.

Conclusions:

  • Congenital hypothyroidism requires prompt diagnosis and consistent management to mitigate cognitive impairment.
  • Regular monitoring of thyroid hormone levels is essential for dose adjustment and optimal therapeutic effect.
  • Continued research into genetic factors and improved treatment adherence is vital for improving patient prognoses.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...